Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine

Neurol Sci. 2021 Nov;42(11):4401-4402. doi: 10.1007/s10072-021-05523-5. Epub 2021 Aug 4.

Authors

Michele Trimboli¹, Pio Zoleo¹, Gennarina Arabia¹, Antonio Gambardella²

Affiliations

¹ Department of Medical and Surgical Sciences, Institute of Neurology, Magna Græcia University, V.le Europa, 88100, Catanzaro, Italy.
² Department of Medical and Surgical Sciences, Institute of Neurology, Magna Græcia University, V.le Europa, 88100, Catanzaro, Italy. a.gambardella@unicz.it.

No abstract available

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Guillain-Barre Syndrome* / etiology
Humans
SARS-CoV-2

Substances

COVID-19 Vaccines
BNT162 Vaccine